Article & News

A quiet but revolutionary milestone may be unfolding in Indian pharmaceutical history—one that could redefine the country’s global positioning not just as a manufacturer of

India has set ambitious goals for air cargo-handling 10 million tonnes by 2030. How realistic is this target, and what role will platforms like ACFI

Traditional cancer therapies aim to destroy tumor cells, often damaging nearby healthy tissue and triggering harsh side effects. Publishing their results in Advanced Science, the

India’s pharmaceutical sector is experiencing significant relief as the prices of Active Pharmaceutical Ingredients (APIs) have dropped sharply, thanks to increased domestic production and aggressive

Imports of bulk drugs and intermediates to India have seen a decline of 2.32 per cent during the first month of the current fiscal year,

New York: AstraZeneca Plc’s experimental breast cancer pill delayed disease progression by over six months, according to data from a new study that is likely

Researchers at the Indian Institute of Science (IISc.) have developed an artificial metal-based nanozyme that can potentially be used to clamp down on abnormal blood

Kiran Mazumdar-Shaw’s booming drug business started not in a laboratory but in a tin-roofed shed in Bengaluru, the city formerly known as Bangalore and the

Indian healthcare sector is poised for a significant transformation, driven by the integration of advanced technologies. Artificial intelligence (AI) is becoming a core component of

In a significant move aimed at strengthening cross-border industrial collaboration, India’s pharmaceutical companies have been invited to explore lucrative partnerships with Saudi Arabia, as the